Table 4.
Comparison of antibody titer levels in HCV infection, diabetes mellitus, and BMI
| Variable | Responder | Nonresponder | p-value |
|---|---|---|---|
| HCV infection | |||
| Positive | 32 (50.0) | 4 (50.0) | >0.999 |
| Negative | 32 (50.0) | 4 (50.0) | |
| Diabetes mellitus | |||
| Positive | 18 (28.1) | 2 (25.0) | >0.999 |
| Negative | 46 (71.9) | 6 (75.0) | |
| BMIa | |||
| Underweight | 22 (16.2) | 2 (25.0) | 0.05 |
| Normal | 57 (41.9) | 6 (75.0) | |
| Overweight | 47 (34.6) | 0 (0) | |
| Obese | 10 (7.4) | 0 (0) | |
| Dialysis duration (mo) | |||
| ≤5 | 34 (53.1) | 4 (50.0) | >0.999 |
| >5 | 30 (46.9) | 4 (50.0) | |
| Lymphocytes (%) | |||
| ≤27 | 72 (52.9) | 6 (75.0) | 0.29 |
| >27 | 64 (47.1) | 2 (25.0) | |
| Significant adverse event | |||
| Fever | |||
| Present | 44 (32.4) | 0 (0) | 0.11 |
| Absent | 92 (67.6) | 8 (100) | |
| Myalgia | |||
| Present | 38 (27.9) | 0 (0) | 0.11 |
| Absent | 98 (72.1) | 8 (100) |
Data are expressed as number (%).
BMI, body mass index; HCV, hepatitis C virus.
a
World Health Organization’s Asian BMI classification.